Merit Medical Systems PE Ratio 2012-2026 | MMSI
Current and historical p/e ratio for Merit Medical Systems (MMSI) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Merit Medical Systems PE ratio as of June 12, 2026 is 19.84.
| Merit Medical Systems PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-06-15 | 66.94 | 28.85 | |
| 2026-03-31 | 68.93 | $2.32 | 29.71 |
| 2025-12-31 | 88.14 | $2.13 | 41.38 |
| 2025-09-30 | 83.23 | $1.95 | 42.68 |
| 2025-06-30 | 93.48 | $1.97 | 47.45 |
| 2025-03-31 | 105.71 | $2.04 | 51.82 |
| 2024-12-31 | 96.72 | $2.03 | 47.65 |
| 2024-09-30 | 98.83 | $2.04 | 48.45 |
| 2024-06-30 | 85.95 | $2.00 | 42.98 |
| 2024-03-31 | 75.75 | $1.74 | 43.53 |
| 2023-12-31 | 75.96 | $1.62 | 46.89 |
| 2023-09-30 | 69.02 | $1.72 | 40.13 |
| 2023-06-30 | 83.64 | $1.55 | 53.96 |
| 2023-03-31 | 73.95 | $1.47 | 50.31 |
| 2022-12-31 | 70.62 | $1.29 | 54.74 |
| 2022-09-30 | 56.51 | $1.07 | 52.81 |
| 2022-06-30 | 54.27 | $1.01 | 53.73 |
| 2022-03-31 | 66.52 | $0.83 | 80.14 |
| 2021-12-31 | 62.30 | $0.84 | 74.17 |
| 2021-09-30 | 71.80 | $0.76 | 94.47 |
| 2021-06-30 | 64.66 | $0.50 | 129.32 |
| 2021-03-31 | 59.88 | $0.07 | 855.43 |
| 2020-12-31 | 55.51 | $-0.18 | 0.00 |
| 2020-09-30 | 43.50 | $-0.52 | 0.00 |
| 2020-06-30 | 45.65 | $-0.53 | 0.00 |
| 2020-03-31 | 31.25 | $-0.07 | 0.00 |
| 2019-12-31 | 31.22 | $0.10 | 312.20 |
| 2019-09-30 | 30.46 | $0.34 | 89.59 |
| 2019-06-30 | 59.56 | $0.70 | 85.09 |
| 2019-03-31 | 61.83 | $0.79 | 78.27 |
| 2018-12-31 | 55.81 | $0.78 | 71.55 |
| 2018-09-30 | 61.45 | $0.72 | 85.35 |
| 2018-06-30 | 51.20 | $0.35 | 146.29 |
| 2018-03-31 | 45.35 | $0.33 | 137.42 |
| 2017-12-31 | 43.20 | $0.55 | 78.55 |
| 2017-09-30 | 42.35 | $0.61 | 69.43 |
| 2017-06-30 | 38.15 | $0.70 | 54.50 |
| 2017-03-31 | 28.90 | $0.67 | 43.13 |
| 2016-12-31 | 26.50 | $0.45 | 58.89 |
| 2016-09-30 | 24.29 | $0.41 | 59.24 |
| 2016-06-30 | 19.83 | $0.50 | 39.66 |
| 2016-03-31 | 18.49 | $0.51 | 36.25 |
| 2015-12-31 | 18.59 | $0.53 | 35.08 |
| 2015-09-30 | 23.91 | $0.59 | 40.53 |
| 2015-06-30 | 21.54 | $0.66 | 32.64 |
| 2015-03-31 | 19.25 | $0.58 | 33.19 |
| 2014-12-31 | 17.33 | $0.53 | 32.70 |
| 2014-09-30 | 11.88 | $0.49 | 24.24 |
| 2014-06-30 | 15.10 | $0.44 | 34.32 |
| 2014-03-31 | 14.30 | $0.44 | 32.50 |
| 2013-12-31 | 15.74 | $0.39 | 40.36 |
| 2013-09-30 | 12.13 | $0.25 | 48.52 |
| 2013-06-30 | 11.15 | $0.29 | 38.45 |
| 2013-03-31 | 12.26 | $0.34 | 36.06 |
| 2012-12-31 | 13.90 | $0.46 | 30.22 |
| 2012-09-30 | 14.93 | $0.56 | 26.66 |
| 2012-06-30 | 13.81 | $0.50 | 27.62 |
| 2012-03-31 | 12.42 | $0.54 | 23.00 |
| 2011-12-31 | 13.38 | $0.58 | 23.07 |
| 2011-09-30 | 13.14 | $0.59 | 22.27 |
| 2011-06-30 | 17.97 | $0.42 | 42.79 |
| 2011-03-31 | 15.70 | $0.40 | 39.24 |
| 2010-12-31 | 12.66 | $0.35 | 36.18 |
| 2010-09-30 | 12.71 | $0.37 | 34.17 |
| 2010-06-30 | 12.86 | $0.60 | 21.43 |
| 2010-03-31 | 12.20 | $0.61 | 20.07 |
| 2009-12-31 | 15.39 | $0.63 | 24.43 |
| 2009-09-30 | 13.86 | $0.64 | 21.66 |
| 2009-06-30 | 13.04 | $0.62 | 21.17 |
| 2009-03-31 | 9.77 | $0.62 | 15.86 |
| 2008-12-31 | 14.34 | $0.58 | 24.56 |
| 2008-09-30 | 15.02 | $0.57 | 26.44 |
| 2008-06-30 | 11.76 | $0.54 | 21.62 |
| 2008-03-31 | 12.66 | $0.48 | 26.38 |
| 2007-12-31 | 11.12 | $0.44 | 25.27 |
| 2007-09-30 | 10.38 | $0.38 | 27.04 |
| 2007-06-30 | 9.57 | $0.36 | 26.58 |
| 2007-03-31 | 10.04 | $0.36 | 27.89 |
| 2006-12-31 | 12.67 | $0.35 | 36.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $4.072B | $1.516B |
| Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |